These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38047925)

  • 21. Incidence of childhood-onset vitiligo and increased risk of atopic dermatitis, autoimmune diseases, and psoriasis: A nationwide population-based study.
    Lim JH; Lew BL; Sim WY; Kwon SH
    J Am Acad Dermatol; 2022 Nov; 87(5):1196-1198. PubMed ID: 35276286
    [No Abstract]   [Full Text] [Related]  

  • 22. Psychological disturbances in patients with pigmentary disorders: a cross-sectional study.
    Dabas G; Vinay K; Parsad D; Kumar A; Kumaran MS
    J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):392-399. PubMed ID: 31566833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychiatric morbidity in vitiligo and psoriasis: a comparative study from India.
    Mattoo SK; Handa S; Kaur I; Gupta N; Malhotra R
    J Dermatol; 2001 Aug; 28(8):424-32. PubMed ID: 11560159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients.
    Elbuluk N; Ezzedine K
    Dermatol Clin; 2017 Apr; 35(2):117-128. PubMed ID: 28317521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of vitiligo and inflammatory arthropathy in hospitalized US adults.
    Patel KR; Justiz AM; Ahmed AM; Silverberg JI
    J Am Acad Dermatol; 2023 Dec; 89(6):1256-1257. PubMed ID: 37532138
    [No Abstract]   [Full Text] [Related]  

  • 26. Comorbid diagnosis of systemic lupus erythematosus in vitiligo: a systematic review and meta-analysis.
    Li HO; Bailey AMJ; Pastukhova E; Tan MG; Kirchhof MG
    Br J Dermatol; 2023 Feb; 188(3):440-441. PubMed ID: 36680305
    [No Abstract]   [Full Text] [Related]  

  • 27. Autoimmune, inflammatory, allergic and neuropsychiatric outcomes of offspring born to mothers with vitiligo: a nationwide Korean population-based birth cohort study.
    Han JH; Ju HJ; Kang H; Lee JH; Lee S; Bae JM
    Br J Dermatol; 2023 Sep; 189(4):488-490. PubMed ID: 37335952
    [No Abstract]   [Full Text] [Related]  

  • 28. The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis.
    Osinubi O; Grainge MJ; Hong L; Ahmed A; Batchelor JM; Grindlay D; Thompson AR; Ratib S
    Br J Dermatol; 2018 Apr; 178(4):863-878. PubMed ID: 28991357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 vaccine-associated vitiligo: A cross-sectional study in a tertiary referral center and systematic review.
    Tsai TF; Ng CY
    J Dermatol; 2023 Aug; 50(8):982-989. PubMed ID: 37186102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of COVID-19 related complications in vitiligo patients: A database study.
    Raiker R; Pakhchanian H; Salingaros S; Helm M
    J Dtsch Dermatol Ges; 2022 Nov; 20(11):1505-1508. PubMed ID: 36210055
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment and Comparison of Quality of Life in Patients with Melasma and Vitiligo.
    Amatya B; Pokhrel DB
    Kathmandu Univ Med J (KUMJ); 2019; 17(66):114-118. PubMed ID: 32632057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation between Association of Psoriasis and Vitiligo.
    Yazdanpanah MJ; Banihashemi M; Pezeshkpoor F; Moradifar M; Feli S; Esmaeili H
    J Cutan Med Surg; 2015; 19(2):140-3. PubMed ID: 25775635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of depression and anxiety among adults with vitiligo in a Malaysian tertiary hospital.
    Ting YL; Ng TG
    Med J Malaysia; 2023 Nov; 78(6):696-704. PubMed ID: 38031209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roadmap to VIRTUAL-GLOBAL: coordinating VItiligo RegisTries for adUlts And chiLdren internationally.
    Eleftheriadou V; Hamzavi I; Bae JM; Ezzedine K
    Br J Dermatol; 2023 Dec; 190(1):114-116. PubMed ID: 37672669
    [No Abstract]   [Full Text] [Related]  

  • 35. Lower Skin Cancer Risk in Vitiligo: DNA Repair as Potential Mechanism?
    Luiten RM
    J Invest Dermatol; 2023 Jun; 143(6):884-885. PubMed ID: 36858901
    [No Abstract]   [Full Text] [Related]  

  • 36. Quality of life in patients with vitiligo: a cross-sectional study based on Vitiligo Quality of Life index (VitiQoL).
    Hedayat K; Karbakhsh M; Ghiasi M; Goodarzi A; Fakour Y; Akbari Z; Ghayoumi A; Ghandi N
    Health Qual Life Outcomes; 2016 Jun; 14():86. PubMed ID: 27267598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitiligo in an urban academic setting.
    Paravar T; Lee DJ
    Int J Dermatol; 2010 Jan; 49(1):39-43. PubMed ID: 20465609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comorbidity Burden Among Patients with Vitiligo in the United States: A Large-Scale Retrospective Claims Database Analysis.
    Ezzedine K; Soliman AM; Li C; Camp HS; Pandya AG
    Dermatol Ther (Heidelb); 2023 Oct; 13(10):2265-2277. PubMed ID: 37668899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Systematic Review on Prevalence and Assessment of Sexual Dysfunction in Vitiligo.
    Saikarthik P; Reddy VH; Rafi SM; Basha VW; Padmakar S
    J Assoc Physicians India; 2022 Oct; 70(10):11-12. PubMed ID: 37355869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plateletcrit values may not be higher in patients with vitiligo.
    Beyan C; Beyan E
    Arch Dermatol Res; 2021 Aug; 313(6):499-500. PubMed ID: 33564893
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.